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1. Introduction 
Dental caries has been identified as one of the most prevalent chronic condition 
and it is a major problem for children all over the world [Millo et al., 2017]. Despite  
the use of preventive systems (improved oral hygiene, usage of fluoride-containing 
toothpaste, fluoride content in drinking water, sealing), international data on 
childhood caries epidemiology confirm that dental caries remains a ‘significant and 
consequential disease of childhood’, being increasingly localized in a subgroup of 
high-risk children, both in developing and developed countries. In 2010, untreated 
caries in permanent teeth was the most prevalent health condition worldwide, 
affecting 2.4 billion people and untreated caries in deciduous teeth was the 10th 
most prevalent medical condition, affecting 9% of the global population [Lambert et 
al., 2017], impacting quality of life through pain, infection, diet, and loss of sleep. 
Caries can also lead to time lost from school for children and time off work for 
parents [Anop et al., 2015]. In addition, oral diseases affect psychologically, 
resulting in difficulty to socialize. In recent years, these conditions have been 
associated with a negative impact on children’s quality of life: cross-sectional 
studies demonstrated that dental caries have been associated with a negative 
impact on the quality of life of children from different age groups [Martins et al., 
2017]. Recent epidemiological surveys indicate a reduction in the prevalence of 
caries in Italy, which is in line with the trend observed in industrialized countries in 
the last decades. Despite this reduction, a polarized distribution of the disease has 
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recently been observed [Ferrazzano et al., 2016]. In some countries, this positive 
trend could deter action to further improve oral health or sustain achievements. It 
might also lead to the belief that caries is no longer a problem, at least in the 
developed countries, resulting in the limited resources available for caries 
prevention being diverted to other areas [Ferrazzano et al., 2016]. However, it must 
be stressed that caries as a disease has not been eradicated, but only controlled to a 
certain degree. The burden of oral disease and needs of populations are in 
transition and oral health systems and scientific knowledge are changing rapidly. 
The etiology of tooth decay is multifactorial and it is induced by three main factors: 
host, environment and bacteria [Fusao et al., 2007]. Today it is known that caries is 
characterized by an early acquisition and overgrowth of several species of 
cariogenic bacteria, such as Streptococcus mutans, Streptococcus sanguinis, and 
Lactobacillus casei [Millo et al., 2017]. Many  studies  have  revealed  that  S. mutans 
represents about the 20-40 % of the cultivable flora in biofilms removed from 
carious lesion and gives its name to a group of seven closely related species 
collectively referred to as the mutans streptococci [Jane et al.,2016]. It is one of the 
main factors for triggering of dental caries because causes demineralization of 
inorganic tooth structure by metabolizing sucrose to lactic acid. It can also colonize 
tooth surfaces and initiate plaque formation through its ability to synthesize and 
bind extracellular polysaccharides (glucan) using the enzyme glucosyltransferase 
[Forssten et al., 2010]. Usually, the appearance of S. mutans in the tooth cavities is 
followed by caries after 6-24 months [Mayooran et al., 2000]. S. mutans and the 
other microorganisms involved in the pathogenesis of dental caries have been 
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considered very difficult to control, because they have developed tolerance and 
resistance to  many antimicrobial agents routinely used in the clinical practice. 
Several antibiotics and antimicrobial agents have been used to eliminate cariogenic 
bacteria from the oral flora. However, their clinical use is limited due to undesirable 
side effects,  including microorganism susceptibility, vomiting, diarrhea, and tooth 
staining. The most commonly used preventive and therapeutic mouth rinses in 
children is chlorhexidine. Chlorhexidine mouth rinse is considered the “gold 
standard” due to its bacteriostatic and bactericidal properties at low and high 
concentrations, respectively. It has been studied for nearly 40 years primarily for its 
ability to reduce gingivitis [Thomas et al., 2015]. Classiﬁed as an antimicrobial agent, 
it has been proven to inhibit the formation and development of dental plaque 
bioﬁlm. However, it can cause a change in taste and produce yellow or brown 
pigments on tooth surfaces.  Therefore, the use of chlorhexidine for caries  
prevention  is controversial, especially in children [Sadat et al., 2015]. Due to 
indiscriminate use of antimicrobials, more and more pathogens are becoming 
resistant and posing a serious threat in rendering successful treatment of the 
diseases. So, the resistance of microorganisms against the antibiotics commonly 
used to treat oral infections, the increasing number of oral pathologies and the lack 
of medications without side effects stressed the importance of further research to 
develop alternative antibacterial agents from natural sources with focus on safety 
for humans and efficacy in the treatment and prevention of dental caries. Since the 
past, the bioactive principles of plant origin have been used for treatment of many 
diseases and microbial infections.  Medicinal plants have been a great source of 
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novel drug compounds since ages. Plant derived products have made large 
contributions to the well being of human health [Giriraju et al., 2013].  In  the  last  
decades,  the  use  of  plants  with  preventive   and therapeutic effects  contributing  
to  health  care has  increased.  Scientists investigated  many plant products in order 
to find their effectiveness in the prevention of dental plaque formation [Rajini Kanth 
et al., 2016]. Numerous medicinal plant extracts have been shown to inhibit the 
formation of dental biofilm  by reducing  the  adhesion  of  microbial  pathogens  to  
the  tooth  surface  or  reducing  the  number of bacteria implicated in the caries  
pathogenesis. Natural phytochemicals would offer an effective alternative to 
antibiotics and drugs; hence, represent a promising approach in prevention and 
therapeutic strategies for prevention of dental caries and other oral infections [E.A. 
Palombo, 2011]. However, only few natural products have found therapeutic 
applications. The reasons of such limited use are due to different factors as: 
effectiveness, stability, smell, taste, and, not last, cost [Ferrazzano et al., 2013]. The 
challenge that we face is how best to deliver these new anti-caries entities at true 
therapeutic levels, over time, to favorably tip the caries balance. There are three 
major problems associated with drug therapy within the oral cavity: rapid 
elimination of drugs due to the flushing action of saliva or the ingestion of food, the 
non-uniform distribution of drugs within saliva on release from a solid or semisolid 
delivery system and patient compliance in terms of taste [Mizrahi et al., 2008]. 
Medicated mucoadhesive tablets could be an effective way for establishing 
sufficient concentrations of antibacterial agents in the oral environment to reduce 
the growth of plaque. Over the past few decades, mucosal drug delivery has 
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received a great deal of attention: mucoadhesive dosage forms may be designed to 
enable prolonged retention at the site of application, providing a controlled rate of 
drug release for improved therapeutic outcome. Application of dosage forms to 
mucosal surfaces may be of benefit to drug molecules not amenable to the oral 
route, such as those that undergo acid degradation or extensive first-pass 
metabolism [Rahamatullah et al., 2011]. 
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2. Aims of the research. 
The aim of this research program was to elaborate a new methodology against 
dental caries, that is based on: 
 
1. identification, characterization  and validation of natural active compounds 
that have anti-caries activity and reduce cariogenic microflora pathogenicity. 
2. The determination of the effectiveness of a novel route of anticaries bio-
active molecules administration by the usage of mucoadhesive buccal drug 
delivery system that can satisfy the patient compliance. 
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3. Natural anti-caries active compounds 
The natural active compounds identified and used in the preparation of  
mucoadhesive tablets were Casein phosphopeptides (CPPs), Stevia rebaudiana 
Bertoni and the hydro-alcoholic extract of,  polyphenol rich, pomegranate (Punica 
granatum L.) peel.  
 
3.1.  Casein phosphopeptides 
Casein phosphopeptides (CPPs) are phosphorylated casein-derived peptides 
produced by proteolytic digestion of s1-, s2-, and ß-casein during the natural 
digestive process in vivo, by action of proteolytic enzymes in vitro, and by 
proteolytic starter cultures during manufacturing of dairy products as fermented 
milk, yogurt and cheese [Bouhallab and Bouglé, 2004; Cai et al., 2003; Ramalingam 
et al., 2005; Walker et al., 2006]. CPPs, containing the sequence Ser(P)-Ser(P)-Ser-
(P)-Glu-Glu, stabilize nanoclusters of amorphous calcium phosphate (ACP) in 
metastable solution. These multiple phosphoseryl residues of the CPPs bind to 
forming nanoclusters of ACP in supersaturated solutions, preventing growth to the 
critical size required for phase transformations. CPPs-ACP localize ACP in dental 
plaque, which buffers the free calcium and phosphate ion activities, helping to 
maintain a state of supersaturation with respect to tooth enamel, depressing 
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demineralization and enhancing remineralization [Cross et al., 2004; Cross et al., 
2005]. In particular, CPPs stabilize calcium and phosphate ions under neutral and 
alkaline conditions forming metastable solutions that are supersaturated with 
respect to the basic calcium phosphate phases. Under these conditions, the CPPs 
bind their equivalent weights of calcium and phosphate . The preventive action of 
CPPs, in vivo, takes place when there are demineralising agents (acid pH), for 
example during a carious or erosive process. That situation can enhance the release 
of calcium from the CPP-ACP complex, thus increasing the Ca cation concentration 
and promoting a supersaturation condition: that will prevent demineralization and 
enhance the remineralization of early enamel caries [Reynolds et al., 2003]. On the 
basis of the generally accepted molecular formula for ACP [Ca3(PO4)2 - nH2O], ACP 
also may be considered a tricalcium phosphate. There is no conclusive evidence that 
ACP is an integral mineral component in hard tissues. It likely plays a special role as 
a precursor to bioapatite and as a transient phase in biomineralization 
[Azarpazhooh and Limeback, 2008]. 
Furtheremore, Guggenheim et al. found that CPP-ACP taken with a cariogenic diet 
in rats significantly reduced the numbers of streptococcus sobrinus by interfering 
with bacterial adherence and therefore colonization [Guggenheim et al., 1995]. In 
addition, a commercial paste containing CPP-ACP has shown to remineralize initial 
enamel lesions [Kumar et al., 2008]. The application of a CPPs toothpaste and 
sodium fluoride (Colgate Neutrafluor 9000 ppm) (NaF) can provide significant 
additional prevention of enamel demineralization when resin-modified glass 
ionomer cement (RMGIC) is used for bonding molar tubes for orthodontic patient as 
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preventive actions [Sudjalim et al., 2007]. An in vitro study to evaluate the 
remineralization of incipient enamel lesions by the topical application of Casein 
Phosphopeptide-Amorphous Calcium Phosphate (CPPACP) using laser fluorescence 
and scanning electron microscope showed high scores of remineralization [Pai et 
al., 2008].  
Other recent in vitro and in vivo experiments have demonstrated that both 
synthetic casein phosphopeptide-amorphous calcium phosphate (CPPs-ACP) 
nanocomplexes contained in mouthrinses and sugar-free chewing gum, and natural 
CPPs contained in dairy products (such yogurt) are anticariogenic [Ferrazzano et al., 
2008; Iijima et al., 2004; Manton et al., 2008; Morgan et al., 2008; Shen et al., 2001]. 
In summary, CPP-ACP complexes have a multiple action mechanism: on one hand, 
providing an oversaturation of calcium and phosphate ions in the dental biofilm and 
saliva, conferring the potential to be biological delivery vehicles for calcium and 
phosphate; on the other hand, inhibiting adhesion of cariogenic bacteria to the 
hydroxyapatite making it possible to modulate the activity of plaque bacteria and 
determines colonization by less cariogenic bacteria. 
Recents studies tested if adding casein phosphopeptide-stabilized amorphous 
calcium phosphate to the Powerade sport drink could be possible prevent erosive 
enamel lesions: enamel samples were analyzed at scanning electron microscope 
(SEM) after erosive immersion test with and without the protective biomolecules to 
evaluate the resulted surface profiles: it was assessed that CPP-ACP included in 
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sport drinks significantly reduced the beverage’s erosion effect on dental enamel 
without affecting the product’s taste [Ramalingam et al., 2005] 
 
 
3.2. Stevia rebaudiana Bertoni 
Stevia Cav. is a genus of herbaceous and shrubby plants distributed exclusively in 
the American Continent, from the Southern United States to Central and South 
America.  
In Central and South America, numerous Stevia species, such as S. salicifolia Cav. 
and S. lucida Lag., have long been known for their ethnopharmacological uses, 
ranging from anti-helminthic to anti-rheumatic and anti-inflammatory applications. 
Certain species are also used as an emetic (S. rhombifolia HBK), for the treatment of 
cardiac conditions (S. cardiatica Perkins) or as anti-diarrheal (S. balansae Hieron, S. 
trifida), whereas diuretic properties have been attributed to S. eupatoria (Spreng.) 
Willd. and S. pilosa Lag. [Soejarto et al.,1983]. Apparently, S. rebaudiana (Bertoni) 
Bertoni, which originated from Northeastern Paraguay, is a unique species 
containing the glycosides stevioside and rebaudioside A, responsible for the sweet 
taste of the leaves [Lemus-Mondaca et al., 2012]. It is a perennial shrub, 
spontaneously growing in the subtropical, mesothermal and humid habitats of 
South America (Figure 1) [Kinghorn et al., 2003]. 
 S. rebaudiana, often referred to as the sweet herb of Paraguay, has been widely 
used in many countries, including China, Japan, Korea, Brazil, and Paraguay, either 
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as a substitute for sucrose in foods and beverages or as a household sweetening 
agent [Soejarto et al, 2002]. The plant is rich in carbohydrates (62% dry weight, dw), 
protein (11% dw), crude fibre (16% dw), minerals (K, Ca, Na, Mg, Cu, Mn, Fe, Zn), 
and essential amino acids [Aminha et., 2014]. 
 
 
Figure 1. Countries of South America where S. rebaudiana grows spontaneously. 
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Figure 2. Regions of the world where it is possible to cultivate S. rebaudiana. 
 
2.3. S. rebaudiana Chemical Constituents and Extraction Procedures 
The extracted active ingredient of S. rebaudiana is a white crystalline substance, 
and it has been used for centuries to sweeten food and beverages by the 
indigenous people of South America. 
The compounds responsible for the natural sweetness of S. rebaudiana leaves 
include diverse diterpenoid glycosides derived from a steviol skeleton. These steviol 
glycosides also exhibit low calorific value, which is interesting for promising 
therapeutic applications, particularly for the treatment of disturbances in sugar 
metabolism. 
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The three major constituents of the leaf extract of S. rebaudiana were stevioside, 
rebaudioside A, and rebaudioside C (from 3% to 17%, by weight) [Kolb et al., 2001;, 
Morlock al at al., 2014]. Other compounds present at lower concentration are: 
steviolbioside, rebaudiosides B, D, E, F, and steviolmonoside [Chaturvedula et al., 
2011, Ohta et al., 2010]. 
 
 
 
         Figure 3. Sweetness of the most common artificial and natural sweeteners. 
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Stevioside, the main sweet component in the leaves of S. rebaudiana (Bertoni) 
Bertoni tastes approximately 300 times sweeter than sucrose. The structures of the 
sweet components of S. rebaudiana, which occur primarily in the leaves, are 
provided in Figure 3. 
Isolated steviosides can be purified using various methods including column 
chromatography, TLC and HPLC methods. Finally the isolated compounds were 
analyzed and characterized using analytical methods such as UV, FTIR, MS, and 
NMR analyses. 
Medicinal and Alimentary Uses of S. rebaudiana Glycosides 
There are three types of S. rebaudiana-based products: the regular products, which 
consist mainly of a stevioside; the Reva A products, which consist mainly of 
rebaudioside A; and the sugar metastasis product. In the regular products, the 
content ratio of stevioside to rebaudioside ranges from 7:3 to 8:2, while in Reva A, 
this ratio is approximately 1:3. Since rebaudioside has a very sweet taste, the 
quality of sweetness for Reva A products is higher than regular ones [Matsukubo et 
al., 2006]. Steviosides offer several advantages over other non-caloric sucrose 
substitutes: they are heat-stable, resistant to acid hydrolysis and non-fermentable 
[Giongo et al., 2014]. 
Further studies have suggested that in addition to sweetness, steviosides and their 
related compounds, including rebaudioside A and isosteviol (a metabolic 
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component of stevioside), may also offer therapeutic benefits. These benefits 
include: anti-hyperglycaemic, anti-hypertensive, anti-oxidant [Kelmer et al.,1985], 
anti-tumor [Jayaraman et al., 2008; Mizushina et al.,2005], anti-  diarrheal, diuretic, 
gastro- [Shiozaki et al., 2006] and renal-protective [Melis et al., 1995], anti-viral 
[Takahashi et al., 2001], and immunomodulatory [Sehar et al., 2008., Boonkaewwan 
et al., 2006] actions.  
Fengyang et al. [Fengyang et al., 2012] examined the anti-inflammatory proprieties 
of stevioside and discovered that stevioside exerts its anti-inflammatory effect by 
inhibiting the activation of NF-κB and mitogen-activated protein kinase signaling 
and the release of pro-inflammatory cytokines. 
The effects of stevioside and its metabolite, steviol, on human colon carcinoma cell 
lines were studied from Boonkaewwan et al. [Boonkaewwan et al. 2008] in 2008. 
Their results demonstrated two biological effects of steviol in the colon: the 
stimulation of Cl(−) secretion and the attenuation of TNF-alpha stimulated IL-8 
production. 
The anti-hyperglycaemic and blood pressure-reducing effects of S. rebaudiana were 
investigated in 2003 by Jeppesen et al. [ Jeppesen  et al., 2003] in a long-term study 
of type 2 diabetic Goto-Kakizaki (GK) rats. According to their results, stevioside may 
determine an increasing of insulin secretion, inducting genes involved in glycolysis. 
It can also: improve the nutrient-sensing mechanisms, rise cytosolic long-chain fatty 
acyl-coenzyme A (CoA), and control down-regulation of phosphodiesterase 1 
(PDE1). They concluded that stevioside demonstrates a dual positive effect: both 
antihyperglycemic and blood pressure-lowering actions. 
 
 
 
18 
As mentioned above, the steviol glycoside is currently used in several countries as a 
sweetener, and it has been extensively tested to demonstrate that its use is safe for 
humans. In 2002, S. rebaudiana ranked second in the sales of herbal supplements in 
the USA. 
According to the Joint FAO/WHO Expert Committee on Food Additives (JECFA, 
2004), the consumption of S. rebaudiana has been generally regarded as safe 
[Tandel  et al., 2011]. 
Aqueous extracts of S. rebaudiana leaves have been approved since 2008 by the 
JECFA as sugar substitutes in many foods and beverages in the Western and Far East 
Asian countries. However, JECFA has requested additional information to change 
the temporary accepted daily intake (ADI) of 0–2 mg·kg−1·day−1 for steviol glycoside. 
The European Union approved stevia additives in 2011 [Beck et al., 2011]. 
 
Caries Prevention Activity of S. rebaudiana Extracts and Steviol Glycosides 
Presently, S. rebaudiana is the only species of the genus with recognized antibiotic 
properties. The antimicrobial effects of S. rebaudiana have been ascribed to the 
presence of stevioside and related compounds, but their role in caries prevention 
and dental health promotion is not fully understood. In 2010, Mohire and Yadav 
[Mohire  et al., 2010] conducted a four week clinical study in patients with oro-
dental problems to develop a chitosan-based polyherbal toothpaste 
(including S. rebaudiana extract). They also evaluated its plaque-reducing ability and 
efficacy in the reduction of dental pathogens using chlorhexidine gluconate 
(0.2% w/v) mouthwash as the positive control. 
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The study involved 18 subjects divided into three groups. The groups were treated 
as follows: Group-I, placebo, toothpaste without chitosan and herbal ingredients; 
Group-II, positive control, CHX (0.2% w/v) mouthwash; and Group-III, test 
(Polyherbal), toothpaste with chitosan, eugenol, and Pterocarpus 
marsupium (PM), S. rebaudiana, and Glycyrrhiza glabra aqueous extracts. Authors 
determined the total microbial count in order to obtain the reduction, in 
percentage, of oral bacterial count during the treatment period. 
At the end of the study, the herbal extracts were shown to possess satisfactory 
antimicrobial activity against most of the dental pathogens. The chitosan-containing 
polyherbal toothpaste significantly reduced the plaque index from 70% to 47% and 
the bacterial count from 85% to 29%. 
The authors concluded that chitosan-based polyherbal toothpaste represented a 
promising novel oral hygiene product compared with the currently available oral 
hygiene products. Nevertheless, in this study, the role of S. rebaudiana in reducing 
antimicrobial count is not clear: this effect, in fact, could be the result of synergic 
action of all active principles involved in the toothpaste. 
In 2013, Giacaman et al. [Giacaman et al., 2013] investigated the cariogenic and 
enamel demineralization potential of several sweeteners in an artificial caries 
model. 
Bovine enamel slabs were utilized as the culture medium for S. mutans UA159 
biofilm that were exposed to different sweeteners in powder or tablet form, as  S. 
rebaudiana extracts, sucralose, saccharin, aspartame, and fructose, three times a 
day for five minutes. The caries-positive and caries-negative controls were 10% 
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sucrose and 0.9% NaCl, respectively. After five days, the biomass, bacterial counts, 
and intra- and extracellular polysaccharides of the biofilm were assessed. Surface 
microhardness was measured before and after the experiment to evaluate enamel 
demineralization, which was expressed as percentage of surface hardness loss 
(%SHL). The results of this study suggest less cariogenic effects and enamel 
demineralization for all tested sweeteners except sucrose. Compared to sucrose, S. 
rebaudiana extracts, sucralose and saccharin reduced the number of viable cells 
(p < 0.05), and all sugar alternative sweeteners reduced extracellular polysaccharide 
formation. Nevertheless the primary limitation of this study is that the artificial 
substrate does not allow a biofilm formation rate comparable with a real clinical 
situation. 
In 2012, Gamboa and Chaves [Gamboa  et al., 2012] evaluated the antibacterial 
activity of S. rebaudiana leaf extracts against cariogenic bacteria. They prepared 
extracts from dried leaves in hexane, methanol, ethanol, ethyl acetate, and 
chloroform, and they evaluated, using well diffusion method, the antibacterial 
capability of the five extracts for 16 bacterial strains of the 
genera Streptococcus (n = 12) and Lactobacillus (n = 4). Lactobacilli were the 
most sensitive, with an inhibition zone between 12.3 and 17.33 mm. Moreover, 
Blauth de Slavutzky [De Slavutzky et al., 2010] conducted an in vivo study to 
evaluate the accumulation of dental plaque after rinsing with a solution of 10% 
sucrose four times daily for five days and compared it to rinsing with the same 
frequency using a 10% solution of S. rebaudiana extract, which was prepared with 
100 g of stevia boiled for 2 h in 3 L of distilled water. Consequently, it was 
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demonstrated that S. rebaudiana, after rinsing, reduced dental plaque between 
57%–82% than sucrose solution, when measured by Silness-Löe index and 10%–40% 
less when measured by O’Leary index of plaque. 
In 2014, Brambilla et al.  evaluated the effect of S. rebaudiana extracts on in vitro S. 
mutans biofilm formation and the in vivo pH of plaque. Three separate 10% 
solutions of stevioside, rebaudioside A and sucrose were prepared. The 
microbological count in vivo was measured using a MTT assay. Twenty volunteers 
rinsed with each solution for one minute and then the plaque pH was analyzed 
seven times after the rinses. Higher in vitro S. mutans biofilm formation was 
observed with the sucrose solution (p < 0.01). After 5, 10, 15, and 30 min, the in 
vivo sucrose rinse produced a statistically significantly lower pH value compared to 
the S. rebaudiana extracts (F = 99.45, p < 0.01). Therefore, S. rebaudiana extracts 
can also be considered non-acidogenic [Brambilla  et al., 2014 16]. 
In 1992, Das et al. [Das et al.,1992] tested stevioside and rebaudioside A for 
cariogenicity in albino Sprague-Dawley rats. The authors divided sixty rat pups 
colonized with S. sobrinus into four groups and fed them their basal diets with 
added stevioside, rebaudioside A or sucrose as follows: group 1, 30% sucrose; group 
2, 0.5% stevioside; group 3, 0.5% rebaudioside A; and group 4, no additional 
chemicals. Significant differences resulted in sulcal caries scores and S. 
sobrinus counts between group 1 and the other three groups. In fact, there was no 
significant difference between the stevioside, rebaudioside A and no-addition 
groups. Thus, neither stevioside nor rebaudioside A were cariogenic under the 
conditions of the study, whose primary limitation is the use of a not human sample. 
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Zanela et al. [ Zanela et al.,2002] investigated the effect of daily mouth-rinse use on 
dental plaque accumulation and on salivary S. mutans in 200 children in 2002. The 
solutions used were: a placebo solution composed of mentholated deionized water 
(group I); 0.12% chlorhexidine gluconate associated to 0.05% sodium fluoride 
(group II); 0.2% chlorhexidine digluconate (group III); and 0.5% stevioside mixed 
with 0.05% sodium fluoride at pH 3.4 (group IV). To verify the accumulation of 
plaque, it was assessed the Löe index method at the beginning and end of the 
experiment. Moreover, the analysis of cariogenic streptococci was accomplished on 
three saliva samples collected at three different times: before the first mouth-rinse, 
24 h after the first mouth-rinse and one week after the last mouth-rinse. The 
mouth-rinsing routine was performed daily for 4 weeks. 
The solution used by group III was the least accepted by children. Furthermore, as 
solution II was utilized by group II, it caused mild dental pigmentation. There were 
no statistically significant differences in the levels of S. mutans, most likely due to 
the low initial levels observed in each of the four groups (Table 1). 
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Table 1- Caries prevention activity of S. rebaudiana extracts and steviol glycosides. 
Authors Year Source Type of 
Study 
Results 
     
Mohire et al.  2010 S. rebaudiana aqueous 
extract (SR) 
In vivo  Reduction of plaque index by 
70.47% 
Giacaman et al.  2013 S. rebaudiana aqueous 
extracts (SR) 
In vitro Reduction of extracellular 
polysaccharide formation 
Gamboa et al.  2012 S. rebaudiana methanol 
and ethanol extracts (SR) 
In vitro Inhibition of growth of 
Lactobacilli  
Blauth de Slavutzky  2010 S. rebaudiana aqueous 
extracts (SR) 
In vivo  Reduction of plaque index 
Brambilla et al.  2014 S. rebaudiana aqueous 
extracts (SR) 
In vitro 
and  
in vivo 
S. rebaudiana extracts are non-
acidogenic  
Zanela et al.  2002 Solution containing 0.5% 
Stevioside and 
Rebaudioside A 
In vivo 
 
Dental plaque reduction was not 
evident using stevioside 
mouthrinses  
Das et al.  
 
1992 Stevioside extracts 
 
In vitro Stevioside and rebaudioside A 
are not cariogenic.  
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3.3. Polyphenols. 
Polyphenols constitute one of the most common and widespread groups of 
substances in plants. Simple phenols consist of a single substituted phenolic ring; 
flavones and their derivatives -flavanoids and flavanols- are phenolic structures 
containing one carbonyl group [Cowan, 1999]. 
Vegetables are the main source of the polyphenols daily intake in human diet, but 
other strong contributors are tea, coffee, cereals and fruit, due to their high 
consumption.  
The biological properties of polyphenols include antioxidant [Balz and Jane, 2003; 
Luczaj and Skrzydlewska, 2005], anticancer [Krishnan and Maru, 2004; Yamane et 
al., 1996; Zhang et al.,2002;] and anti-inflammatory [Sang et al., 2004] effects. 
In the last years, polyphenols from some edible plants have attracted attention as 
potential sources of agents capable of controlling the growth of oral bacteria 
[Taguri et al., 2004]. 
Polyphenols could be able to influence the process of caries formation at crucial 
different stages. In fact, they have been shown to inhibit the adherence of mutans 
streptococci to saliva-coated hydroxyapatite [Smullen et al., 2007]. Polyphenols are 
able to interact with microbial membrane proteins, enzymes, and lipids, thereby 
altering cell permeability and permitting the loss of protons, ions, and 
macromolecules [Ikigai et al., 1993]. It has been, in fact, demonstrated that when S. 
mutans was pretreated with Sunphenon (a mixture, containing polyphenols), its 
cellular attachment to a saliva-treated hydroxyapatite surface was significantly 
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reduced, showing that the phenomenon was a consequence of a specific interaction 
with the bacteria [Otake et al., 1991]. 
In addition, several works have demonstrated that polyphenols inhibit in vitro the 
glucosyltransferases activity of S. mutans (GTases) [Hattori et al.,1990; Kashket et 
al., 1985;Ooshima et al.,1993; Sakanaka et al., 1989].  
Experiments also demonstrate the inhibition of salivary amylase activity by 
polyphenols. The effect on salivary amylase may contribute significantly to reduce 
the cariogenicity of starch-containing foods [Kashket and Paolino; 1988]. 
 
3.3.1. Pomegranate. 
Pomegranate (Punica granatum L.) is a common fruit of a tree belonging to the 
family Punicaceae. It is native to the region from northern India to Iran and it has 
been cultivated and naturalized over the entire Mediterranean region since ancient 
times. The ripe fruit is about five inches wide with a deep  red,  leathery  skin,  
grenade  shaped  with  a  pointed  calyx.  The  fruit  contains  many seeds separated 
by white membranous pericarp. Each seed is surrounded by tart and red juice 
[Divyashree et al., 2014].  
Pharmacological properties of pomegranate have a long history, but, in the recent 
decades, the interest in evaluating therapeutic effects of pomegranate has 
increased noticeably. Studies show that pomegranate juice has potent antioxidant 
activity (capability to scavenge free radicals) due to its high polyphenols content, 
including ellagitannins (hydrolysable tannins) and anthocyanins (condensed 
tannins). There is a range of phytochemical compounds in pomegranate that have 
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showed antimicrobial activity, but most of the researchers have found that ellagic 
acid and larger hydrolyzable tannins, such as punicalagin, have the most important 
activities. In many cases, the mixture of the pomegranate constituents offers the 
most advantage [Howell et al., 2013]. This fruit has also been used in traditional 
medicine for the treatment of dysentery, diarrhea and respiratory pathologies 
[Ismail et al., 2012; Dey et al., 2015]. Many studies indicate that pomegranate 
extracts may be employed as natural alternative for the treatment of a wide range 
of bacterial and viral infections due to their antimicrobial activity. Recent study 
indicate that both pomegranate aril and peel extracts have an effective 
antimicrobial activity, as evidenced by the inhibitory effect on the bacterial growth 
of two important human pathogens,  including  Staphylococcus  aureus  and  
Escherichia  coli,  often  involved  in foodborne illness [Pagliarulo et al., 2017]. In 
addition, experimental data strongly support the antibacterial activity of 
pomegranate extracts against oral pathogen such as S. mutans. 
 
 
 
 
 
 
 
 
 
 
 
 
27 
4. Experimental Studies Section. 
 
The intent of this research program was to determine a new way in caries 
prevention. Literary evidences and previous studies conducted in the Department 
of Neuroscience, Reproductive and Oral Sciences, Section of Paediatric Dentistry, 
University of Naples, Federico II, Naples [Ferrazzano et al.,2011;Ferrazzano et al., 
2012] had already  demonstrated the regular efficacy of natural compounds such as 
CPPs in preventing dental caries. 
 
 
 
Therefore, in this present research activity, we decided to perform experimental 
microbiological studies order to evaluate: 
 
 
1. The antibacterial activity of pomegranate extracts against cariogenic 
bacteria. 
 
2. The in vitro evaluation of cytotoxic effects of experimental mucoadhesive 
tablets, containing Stevia, CPPs and pomegranate extract, object of the 
research program. 
 
3. The in vivo compliance of mucoadhesive tablets as model drugs for 
sustained local action. 
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4.1.In Vitro Antibacterial Activity of Pomegranate Juice and Peel Extracts on 
Cariogenic Bacteria. 
 
 Materials and Methods 
 Preparation of Extracts for Microbiological Assay. 
 Fresh fruits of pomegranate (P. granatum L.) were collected from trees located in 
the countryside of Avellino (Southern Italy) during fruit season. The fruits were 
handpicked, washed, and peeled, and the arils, without seeds, were hand-crushed 
and then squeezed in order to obtain the juice. The peel was air dried a few days 
and then pulverized. The samples were stored at −20∘C for further analysis. The 
juice was defrosted at room temperature. Solution water/ethanol 25 ml 50% (v/v) 
was added to 5 g of juice. The same procedure was carried out for the peel powder. 
Each sample was mixed for 30 minutes, and then the extracts were filtered. The 
analysis of phenolic compounds of the pomegranate (juice and peel) was performed 
by reverse phase HPLC (RP) coupled offline mass spectrometry (MS) MALDI-TOF . 
For microbiological assays, the ethanolic extracts of juice and peel were dried in 
Savant in order to calculate the percentage yield of total polyphenols. Each extract 
was reduced in volume in a rotavapor, transferred into a plastic tube, and finally 
lyophilized. The hydroalcoholic extracts of pomegranate peel and juice were used. 
 
 
 
 
29 
Microorganisms and Growth Conditions. 
 The antimicrobial activity of the pomegranate extracts was evaluated against the 
strain Streptococcus mutans Clarke ATCC 25175 (LGC Standards, UK) isolated from 
carious dentine and Rothia dentocariosa clinical isolate Rd1, obtained from samples 
of dental plaque provided from the Pediatric Dentistry Department of “Federico II” 
University, Naples, Italy. Permission to take dental plaque samples was acquired 
according to the local planning authorities. Furthermore, approval for this study was 
granted by the ethics committee of the “Federico II” University, Naples, Italy 
(Protocol number 101/14). 
The identification of clinical isolates was performed, from UOC of Clinical 
Microbiology, AOU “Federico II” of Naples, Italy, by mass spectrometry using the 
Matrix Assisted Laser Desorption/Ionization (MALDI) mass spectrometer (Bruker 
Daltonics, MALDI Biotyper, Fremont, CA, USA), a high-throughput proteomic 
technique for identification of a variety of bacterial and fungal species [Neville  et 
al., 2011; Sogawa  et al., 2011], and biochemicalphenotyping method in an BD 
Phoenix Automated Microbiology System (Becton Dickinson, BD Franklin Lakes,NJ, 
USA), according to the manufacturer’s instruction. Bacteria were cultured 
aerobically in broth and agar media at 37∘C. The media used were Brain Heart 
Infusion(BHI) (Oxoid, S.p.a., Rodano, Milano, Italy), Columbia CAN with 5% Sheep 
Blood with Colistin and Nalidixic Acid (Oxoid, S.p.a., Rodano, Milano, Italy), and 
Mueller-Hinton (Simad s.a.s., Naples, Italy). Microbial strains were maintained at 
4∘C on agar media. The isolates were stored frozen at −80∘C in BHI broth 
supplemented with 10% glycerol (v/v)(Carlo Erba, Reagents, Milan, Italy) until use 
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and the working cultures were activated in the respective broth at 37∘C for 15–18 
h. 
In Vitro Antibacterial Activity Assays.  
The susceptibility of S. mutans ATCC 25175 and R. dentocariosa Rd1 to different 
concentrations of Punica granatum L. fruit extracts was determined by dilution tube 
method with 1 × 105 CFU/ml as standard inoculums.  The extracts were added in 
the series of tubes achieving final concentrations of 0, 5, 10, 15, 20, 30, 40, 60, 100, 
and 140 𝜇g/𝜇l, and tubes were incubated at 37∘C for 24 h. As positive control the 
bacterial strains were tested with ranging concentrations of Ampicillin (Sigma-
Aldrich, Milano, Italy) and with extraction buffer as negative control. After 
incubation, the optical density at 𝐴600 nm was determined; subsequently an 
aliquot of each sample was spread into BHI-agar plates in duplicate and then 
incubated for 24–48 h for the evaluation of viable counts. Minimum inhibitory 
concentration (MIC) was assigned to lowest concentration of pomegranate extract, 
which prevents bacterial growth. The minimum bactericidal concentration (MBC) 
was defined as the minimum extract concentration that killed 99% of bacteria in the 
initial inoculums. To verify the effect of pomegranate juice and peel hydroalcoholic 
extracts on the fitness of S. mutans ATCC 25175 and R. dentocariosa Rd1, assays of 
bacterial growth and survival were performed in presence of increasing 
concentrations of the extracts. To evaluate the fitness of each strain, during the 
observation period (96 h), serial dilutions were spread on BHI-agar and incubated at 
37∘C for 24–48 h to evaluate viable counts. All experiments were performed in 
triplicate, with three independent cultures; the results obtained were analyzed and 
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graphically reported by using “GraphPad Prism6” software. Results are presented as 
mean ± SD. The statistical significance was determined by the two-way ANOVA test 
with a Bonferroni correction (𝑃 value ≤ 0.05). 
3. Results 
3.1. In Vitro Antibacterial Activity of Pomegranate Extracts. 
 The antimicrobial activity of pomegranate extracts against S.mutans ATCC 25175 
cariogenic strain and R. dentocariosa Rd1 clinical isolate was evaluated by dilution 
tube method, according to the CLSI (Clinical and Laboratory Standards Institute) 
guidelines. Growth of S. mutans ATCC 25175 strain and R. dentocariosa Rd1 clinical 
isolate was inhibited with a concentration of pomegranate juice extract equal to 25 
𝜇g/𝜇l and 20 𝜇g/𝜇l, respectively. Pomegranate juice extracts showed a MBC value of 
40 𝜇g/𝜇l against S. mutans ATCC 25175 and a MBC value of 140 𝜇g/𝜇l against R. 
dentocariosa Rd1. The pomegranate peel extracts exhibited a MIC value of 10 𝜇g/𝜇l 
and a MBC value of 15 𝜇g/𝜇l against both microorganisms tested. Both the bacteria 
tested in this study are sensitive to ampicillin. 
 
Effects of Pomegranate Extracts on Bacterial Fitness. 
To verify the effect of pomegranate juice and peel hydroalcoholic extracts on the 
fitness of S. mutans ATCC 25175 cariogenic strain and R. dentocariosa Rd1 clinical 
isolate, the growth and survival were evaluated for 96 h, with increasing 
concentrations of hydroalcoholic extracts. The pomegranate juice extracts exhibited 
inhibitory effect on growth and survival of both strains (Figure 4). The growth 
evaluation was biased by the turbidity of the extracts, as clearly showed by growth 
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curves (Figures 4(a) and 1(c)). However, the evaluation of viable counts had 
highlighted a strong bactericidal activity of  pomegranate juice hydroalcoholic 
extract with a concentration of 40 𝜇g/𝜇l for S. mutans ATCC 25175 and a moderate 
bactericidal effect against R. dentocariosa Rd1 with a concentration of 140 𝜇g/𝜇l 
(Figures 4(b) and 4(d)). 
 
 
Figure 4: Effect of pomegranate juice extracts on (a) growth of S. mutans at 
different concentration (0, 20, 30, and 40 μg/μl); (b) survival of S. mutans at 
different concentration (0, 20, 30, and 40 μg/μl); (c) growth of R. dentocariosa at 
different concentration (0, 20, 30, 60, and 140 μg/μl); (d) survival of R. dentocariosa 
at different concentration (0, 20, 30, 60, and 140 μg/μl). 
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Interestingly, the pomegranate hydroalcoholic peel extract exhibited a strong 
inhibitory activity against both tested cariogenic strains (Figure 5). The 
hydroalcoholic peel extracts interfered with the bacterial growth, survival, and 
fitness in a dose dependent manner and with time-lasting effects, as previously 
described for other clinical isolates [Pagliarulo et al., 2016]. In addition the 
bactericidal activity is detectable at a very low concentration equal to 15 𝜇g/𝜇l for 
both strains. The peel extracts in ethanol were cloudy so it was impossible to test it 
in the bacterial growth assay. 
 
 
Figure 5: Effect of pomegranate peel extracts on survival of S. mutans (a) and R. 
dentocariosa (b) at different concentration (0, 5, 10, and 15 μg/μl). 
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Conclusions 
 In vitro microbiological assays demonstrated that pomegranate (Punica granatum 
L.) hydro-alcoholic peel and juice extracts are able to counteract cariogenic bacteria 
of dental plaque. In fact, the extracts showed inhibitory effect on the growth and 
survival of S. mutans ATCC 25175 and R. dentocariosa Rd1 isolate, considered 
among the most important etiological agents of tooth decay. The strongly 
bactericidal power of the pomegranate fruit extracts against oral cariogenic bacteria 
suggests further deep investigation. 
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 Development of new experimental tablets.   
 As above mentioned, the drug therapy within the oral cavity is not completely 
effective in maintaining therapeutic concentrations at the site of action.                                                                                                
Various disadvantages result in the short retention time of the drugs, such as the 
rapid loss of drug from the site of absorption by means of salivary action and 
mechanical stress, the  inadequate distribution of drugs within the areas of oral 
cavity, the patient discomfort due to unpleasant taste sensations and the barrier 
effect of oral mucosa [Perioli et al., 2008]. 
A solution to these problems could be the design of mucoadhesive sustained 
release products capable of retaining the device in the oral cavity so it keeps the 
drug concentration within the therapeutic range, in order to require less frequent 
administrations. Therefore, mucoadhesive systems may represent valid alternatives 
in light of their easiness to use because they can be applied and removed directly by 
patients. In collaboration with the Nutrition Science Institute of Avellino, our 
scientific group performed  new slow-release tablets , designed for being settled on 
the inner-mouth mucosal surface, in close contact with gingival tissues. In this way, 
the tablets can release their active load gradually, during the daily activities of the 
mouth. Tablets are designed to be applied to different regions of oral cavity, such as 
cheeks, lips, gums, and palate and can allow drinking, eating, and speaking without 
any major discomfort. The tablets main content  consists of natural active anti-
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caries compounds such as CPP-ACP, stevia rebaudiana Bertoni  and pomegranate 
peel extractand a mixture of excipients  was also used in the design . 
 
Manifacturing of medicated tablets. 
A powder or granule mixture containing all the ingredients was prepared, using a 
lab mixer (HulaMixer Sample Mixer); a physical blend magnesium stearate was 
homogeneously mixed with the blend in order to optimize the compression process. 
To get the final product the powder mix was compressed by a single punch 
machine(Matrix 2.2 A, Ataena Srl, Ancona, Italia) at room temperature. The tablets 
obtained were blistered and stored at temperatures below 20 ° C. 
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4.3. In vitro cytotoxicity of slow-release  tablets  containing CPPs, Stevia and 
pomegranate extract, on  human gingival fibroblasts.  
Slow-release tablets are designed for being settled on the inner-mouth mucosal 
surface, in close contact with gingival tissues. In this way, the tablet releases its 
active load gradually, during the daily activities of the mouth. As the prolonged 
contact of the tablets with the mucosa could possibly interfere with the normal 
turnover of the mucosal cells or determine detectable alterations, it was decided 
first to directly test in vitro the effects of our tablets laying down on a monolayer of 
human gingival fibroblast (HGF-1, ~80% of confluence) for a prolonged time (up to 
one week). In addition, the effect of the active content extracted from tablets with 
a solvent at increasing concentrations on the same cell strain was tested, as above. 
 
Materials and methods 
Slow-release tablets containing Pomegranate Peel extract, stevia and Cpps  were 
kept in sealed blisters in the refrigerator at +4°C until used. One percent (1%) 
methylene blue solution for staining was prepared freshly by dissolving the dry 
powder (Sigma Aldrich) in ethanol/PBS (1:1). Human Gingival Fibroblasts (HGF-1) 
cell line was from ATCC (Rockville, MD, USA). Cells were cultured in Dulbecco’s 
Modified Eagle Medium (DMEM), containing 10% Fetal Bovine Serum (FBS), 2 mM 
L-glutamine, and 1% penicillin/streptomycin and maintained in 5% CO2 at 37°C with 
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96% relative humidity (pH 7.4). Cell culture medium and serum were both 
purchased from Gibco (Invitrogen).  
 
Treatments 
Cells - About 3.5x105 cells were seeded in 60-mm tissue culture dishes. The 
experiments described below were initiated when the attached cells reached 80-
90% of confluence. 
Intact tablets - Slow-release tablets were gently set down in the middle of the tissue 
culture dishes where remained immersed for 6 days. Every day, after cells washing 
with warm PBS (twice), the culture medium was carefully replaced. The sixth day, 
the tablets leftovers were cautiously removed and cells were stained for 2 hours 
with methylene blue in ethanol/PBS. 
Dissolved tablets - In this case, fixed volumes (2 mL) of phosphate-saline buffer 
isotonic solvent (PBS) were slowly poured on a tablet with stirring. As the tablet 
matrices were insoluble, this material was separated by the clear surnatant by 
extended centrifugation and filtration. This clear solution (stock solution) was used 
immediately after its preparation. Aliquots of this solution (1 tablet/2 mL PBS) were 
added to cells (from 0 to 200 μL). After 24 hours, cells where washed twice with 
warm PBS and finally stained for 2 hours with methylene blue in ethanol/PBS.  
The medium around each tablet was gently aspired and prudently replaced. This 
operation was repeated every day for one week. Finally, after the removal of tablets 
from the plates, the cells were stained with methylene blue. This procedure was to 
evaluate potential effects of tablets on cell survival and growth  
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Results   
Slow-release tablet itself and its content do not interfere with physiologic cell 
growth in vitro.  During  the in vitro  experiment, using the intact tablet, an increase 
of the tablet size was observed; this increase, due to its extended soaking, is 
certainly accompanied by a continuous release of its active content into the 
medium. Except for a factitious spot in the middle of the plate (where the tablet 
had been setting for a week), it appears that the cells continue to grow normally 
(Figure 6). Moreover, as result of the second test, performed using dissolved 
tablets, staining with methylene blue solution demonstrates that cell physiological 
growth was not affected in all tested conditions (Figure 7). 
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Figure 6. Monolayer of HGF-1 during and after treatment with slow-release tablet. 
Panel a: On the left: control cells; on the right: cells growing in the presence of the 
tablet. While releasing progressively its active content, the tablet appears to 
increase its size, as it got soaked. Pictures were taken daily. Panel b: The last day of 
treatment before (upper picture) and after tablet removal and cells staining (lower 
picture). Panel c: Approximate tablet diameter with soaking time. 
 
 
day 1
day 2
day 3
day 4
day 5
a
y = 0,68x + 1,1433
R² = 0,9458
0
1
2
3
4
5
6
0 1 2 3 4 5 6 7
ca
p
su
le
 d
ia
m
e
te
r 
(a
rb
it
ra
ry
 u
n
it
s)
days
b
c
day 6
cnt capsule
 
 
 
41 
 
Figure 7. Methylene Blue staining of HGF-1 monolayer after 24 hours of incubation 
with specified volumes of tablet extract. No significant alterations of cells growth 
are evident as compared to control (two similar, separate experiments were carried 
out simultaneously).  
 
 
 
Conclusions 
In this trial, toxicity studies were conducted to determine the possible toxic effects 
of Slow-release tablets containing Pomegranate Peel extract, stevia and Cpp  on 
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human gingival fibroblast (HGF-1, ~80% of confluence) for a prolonged time (up to 
one week). In addition we tested the effect of the active content extracted from 
tablets with a solvent at increasing concentrations to provide credible information 
for the future application of the tablets. Our findings revealed that the Slow-release 
tablets experimented and its content do not interfere with physiologic cell growth 
in vitro.  These results provide important information for the further use of slow 
release-tablets in the prevention of dental caries . 
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4.3.In vivo  evaluation of controlled release mucoadhesive tablets containing 
containing stevia rebaudiana Bertoni, CPPs and pomegranate peel extract. 
 
This trial describes the preliminary clinical evaluation of mucoadhesive slow release 
formulations containing stevia rebaudiana Bertoni, CPPs and pomegranate peel 
extract. Each formulation was characterized in terms of adhesiveness, tolerability, 
and patient’s compliance. 
 
 Materials and Methods 
The study was conducted in accordance with the Declaration of Helsinki (World 
Medical Association, 2001). Ethical approval was granted by the “Federico II” 
University of Naples, Italy ( Protocol number: 101/14). 
The trial was carried out in May 2017 among a sample of 40, 12 to 14 years-old,  
children. Only Patients in good general health with caries-free, completely erupted 
first and second permanent molars were included in the study. Parents were 
informed about the study by a verbal and written explanation of the protocol and 
the aim and then they were invited to give their written consent to the study. 
The study lasted seven days; volunteers for each day were instructed to press 
against gums, above upper second molar, the slow release tablets without 
moistening them before application. Residence tablet time, possible irritation, loss 
of fragments, bad taste, dry mouth or excessive salivation have been evaluated 
using self-report questionnaires. 
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The persistence of the adherence of the tablets was checked at the application (t0), 
after 6 hours (t1) and 12 hours (t2) by two examiners.        
Two standardized dentists performed a comprehensive dental examination for all 
40 patients under artificial light (portable 60w lamps) using a plane buccal mirror 
and a dental explorer. 
To evalue the parameters of adhesiveness and irritation, the examiners were 
calibrated at the Department of Neuroscience, Reproductive and Oral Sciences, 
Section of Paediatric Dentistry, University of Naples, Federico II, Naples, Italy. A sub-
sample of fifty subjects was observed independently by the two examiners as a tool 
for standardizing examination procedures: agreement was assessed by means of k 
statistic (k = 0.935) (CI 95% 0.777-0.975) for DMFT score.  
At the end of the treatments the data were processed with the Statistical Package 
for Social Sciences (version 10.0, SPSS Inc., Chicago, Illinois, USA). A regression 
binary logistic analysis was made. Statistical significance level was established at p < 
0.05. 
 
 
Results   
 Forty-one patients were consecutively enrolled in the study. Among them, four 
were dropped from the study because of discontinuation for the final assessment. 
Thirty-seven patients completed the study. Of the 37 patients, 16 (43.2%) were 
females and 21 (56.8%) were males with a mean age of 15.05±14.7 years (range: 
14-16 years). 
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T0 
At the first application tablets adhered in 93. 8% of the cases, while 6. 26% patients 
were not able to attach the tablets against the gum (Table 2). In 2.9% of the cases 
the first application of the tablet resulted uncomfortable for the patients, while in 
97.1% patients did not feel any disturb. In 2.1% of the cases patients referred 
sensation of burning. In 81.5% of the cases the tablets did not have any taste. 
 
Clinical examination.  
Examiners referred that at T0 93.8% of the tablets were steadily adherent to the 
gum. At the first application no sign of inflammation of soft tissues was reported. 
 
 
 
 
 
Table 2: adhesion at T0. 
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T1  
6 hours after the application, tablets resulted lost in just 2.9% of the cases, while 
stayed attached in the remaining 97.1%.  At T1 in 30.1% of the cases the tablet 
resulted uncomfortable for the patients, in 76.1 % of the cases they reported a 
slight discomfort, in 15.5% the discomfort was moderate and just in 8.4% of the 
cases patients referred a high annoyance. In 8.1% of the cases patients referred 
sensation of burning and only in 7.2 % of the cases sensation of dryness .In 97.5% of 
the cases the tablets did not have any taste. 
Clinical examination 
At T1 45.8% of the tablets were still intact, on the contrary the remaining 54.2% was 
partially solved. Patients tissue resulted slightly inflamed only in 28.8% of the cases, 
while in   168 cases (64.9%) no sign of inflammation or irritation was found.  In 
89.9% of the cases tablets were steadily adherent to the gum yet.  
 
T2 . 
12 hours after the application, tablets resulted lost in just 5,5% of the cases, while 
stayed totally attached  in 94,5%. At T2 in 36.6% of the cases the tablet resulted 
uncomfortable for the patients, in 100% of the cases they reported a slight 
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discomfort, in 0% the discomfort was moderate or high .No one of the patients 
reported sansation of dryness or burning .In 80.8% of the cases the tablets did not 
have any taste. 
Clinical examination 
At T2 86.1% of the tablets  were partially solved, on the contrary  the remaining 
13.9% was yet intact. Patients tissue resulted slightly inflamed only in 26.3% of the 
cases, while in   168 cases (64.9%) no sign of inflammation or irritation was found.  
In 89.9% of the cases tablets were steadily adherents to the gum yet. 
 
Statistical analysis. 
The differences in adhesivness between T0 and T1, T0 and T2, T1 and T2 were not 
statistically significant, respectively (Fig.8). 
 
 
 
 
Table3: Statistical analysis within the test gr statistical analysis concerning the 
degree of adhesion. 
 
 
 
Sig. OR 
95,0%C.I. 
Lower Upper 
T 0 - T1 .08 2.22  0.89  5.49 
T1 - T2 .15 .50 .19 11.29 
T0 - T2 .75 1.12 .53 2.40 
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Figure 8. 
 
 
Conclusion 
The tablets investigated in this study were acceptable to many patients and since 
there is a potential role for aslow-release tablets in preventing oral disease in this 
group its clinical effectiveness needs to be evaluated. 
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5. GENERAL CONCLUSIONS. 
Dental caries is still the main health problem worldwide both in more developed 
and in lower income countries [Bourgeois et al., 2014] and bacteria have been 
suggested to cause the strongest effect on the prevalence or incidence of dental 
caries. The final score of this research was the creation of a new preventive 
methodology against dental caries by using new mucoadhesive formulations that 
could offer many advantages in comparison to traditional treatments and could be 
proposed as a new therapeutic tool against dental disease. The studies carried out 
in recent decades in our departments  allow us to define that CPP-ACP could 
contrast dental caries and erosion; furthermore results of experimental protocols 
have supported the antibacterial role of polyphenols, such as pomegranate extract, 
and their potential use in the control of bacteria responsible of caries. In vitro 
microbiological assays demonstrated, indeed, that pomegranate (Punica granatum 
L.) hydro-alcoholic peel and juice extracts are able to counteract cariogenic bacteria 
of dental plaque. The in vivo trial suggests that the usage of mucoadhesive buccal 
drug delivery system could be a novel route of anticaries bio-active molecules 
administration by offering prolonged contact at the site of administration and 
satisfying the compliance of the patients. More studies, particularly in vivo and in 
situ, are necessary to clarify the synergic effects of the different active principles 
insert in the tables and their clinical applications in contrasting dental caries. 
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